Buscar
Novanta Inc
NOVTAñadir a la lista de seguimiento
142.550USD
+3.640+2.62%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
5.08BCap. mercado
101.50P/E TTM
Más Datos de Novanta Inc Compañía
Novanta Inc. is a supplier of core technology solutions, which offer medical and advanced industrial original equipment manufacturers. Its segment includes Automation Enabling Technologies and Medical Solutions. The Automation Enabling Technologies segment designs, manufactures and markets laser beam delivery components, laser beam delivery solutions, CO2 lasers, solid state lasers, ultrafast lasers, optical and inductive encoders, precision motors, integrated stepper motors, servo drives, motion control solutions, intelligent robotic end-of-arm technology solutions, and air bearing spindles to customers worldwide. The Medical Solutions segment designs, manufactures and markets a range of medical grade technologies, including medical insufflators and endoscopic pumps and related disposables, laser beam delivery solutions, video processing and streaming and capture, machine vision technologies, radio frequency identification (RFID) technologies, thermal chart recorders, and others.
Información de Novanta Inc
Símbolo de cotizaciónNOVT
Nombre de la empresaNovanta Inc
Fecha de salida a bolsaMar 24, 1999
Director ejecutivoGlastra (Matthijs)
Número de empleados3000
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 24
Dirección125 Middlesex Turnpike
CiudadBEDFORD
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal01730-1409
Teléfono17812665618
Sitio Webhttps://www.novanta.com/
Símbolo de cotizaciónNOVT
Fecha de salida a bolsaMar 24, 1999
Director ejecutivoGlastra (Matthijs)
Ejecutivos de Novanta Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Robert J. Buckley
Mr. Robert J. Buckley
Chief Financial Officer
Chief Financial Officer
132.84K
--
Mr. Matthijs Glastra
Mr. Matthijs Glastra
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
84.14K
-7.72%
Mr. Lonny J. Carpenter
Mr. Lonny J. Carpenter
Lead Independent Director
Lead Independent Director
5.85K
--
Ms. Maxine Lum Mauricio
Ms. Maxine Lum Mauricio
Independent Director
Independent Director
4.55K
--
Mr. Frank Anders (Andy) Wilson, CPA
Mr. Frank Anders (Andy) Wilson, CPA
Independent Director
Independent Director
3.95K
--
Mr. John Lesica
Mr. John Lesica
Co-Chief Operating Officer - Medical Solutions
Co-Chief Operating Officer - Medical Solutions
2.10K
--
Mr. Thomas N. Secor
Mr. Thomas N. Secor
Independent Director
Independent Director
1.32K
--
Mr. Ray Nash
Mr. Ray Nash
Corporate Finance Leader, Investor Relations
Corporate Finance Leader, Investor Relations
--
--
Dr. Darlene J. S. Solomon, Ph.D.
Dr. Darlene J. S. Solomon, Ph.D.
Independent Director
Independent Director
--
--
Ms. Mary Katherine (Mary Kay) Ladone
Ms. Mary Katherine (Mary Kay) Ladone
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Robert J. Buckley
Mr. Robert J. Buckley
Chief Financial Officer
Chief Financial Officer
132.84K
--
Mr. Matthijs Glastra
Mr. Matthijs Glastra
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
84.14K
-7.72%
Mr. Lonny J. Carpenter
Mr. Lonny J. Carpenter
Lead Independent Director
Lead Independent Director
5.85K
--
Ms. Maxine Lum Mauricio
Ms. Maxine Lum Mauricio
Independent Director
Independent Director
4.55K
--
Mr. Frank Anders (Andy) Wilson, CPA
Mr. Frank Anders (Andy) Wilson, CPA
Independent Director
Independent Director
3.95K
--
Mr. John Lesica
Mr. John Lesica
Co-Chief Operating Officer - Medical Solutions
Co-Chief Operating Officer - Medical Solutions
2.10K
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Novanta Inc?
Los cinco principales accionistas de Novanta Inc son: Mr. Robert J. Buckley
¿Cuántas instituciones poseen acciones de Novanta Inc (NOVT)?
A fecha de 2026Q1, 714 instituciones poseen acciones de Novanta Inc, con un valor de mercado combinado de aproximadamente 46.22M, lo que representa el 129.80% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 7367840.00.